Some upcoming presentations (from PCYC's web site):
American Society of Therapeutic Radiation Oncology (ASTRO)
October 25-29, 1998
Phoenix, AZ
October 27, 1998
2:00 p.m.-3:30 p.m.
Poster Session -- Viewing Only
Abstract #2071: "Pharmacokinetics of the Radiation Sensitizer Gadolinium Texaphyrin in a Phase Ib/II Trial for Patients with Brain Metastases Receiving Whole Brain Radiation"
Abstract #2072: "Selective Uptake and Retention of the Radiation Sensitizer Gadolinium Texaphyrin (Gd-Tex) in Tumors Demonstrated by MRI in Phase I and II Clinical Trials"
October 28, 1998
2:30 p.m.
Oral Presentation #147
"Phase Ib/II Trial of the Radiation Sensitizer Gadolinium Texaphyrin (Gd-Tex) for Patients with Brain Metastases: Final Results"
NOVEMBER
American Heart Association (AHA)
November 8-11, 1998
Dallas, TX
November 9, 1998
9:15 a.m.-9:30 a.m.
Oral Presentation #500973
"Photoangioplasty with ANTRINTM: A Photosensitizer that Selectively Accumulates in Atheromatous Plaque and is Detectable by Fluorescence Imaging"
November 9, 1998
9:30 a.m.-9:45 a.m.
Oral Presentation #501065
"Photoangioplasty of Human Atherosclerosis with ANTRINTM"
Society of Neuro-Oncology (SNO)
November 15, 1998
San Francisco, CA
November 15, 1998
10:15 a.m.-10:30 a.m.
Oral Presentation
"Gadolinium Texaphyrin (Gd-Tex), A Tumor Selective Radiation Sensitizer for Primary and Metastatic Brain Tumors"
|
